Newsletter | December 23, 2024

12.23.24 -- How To Identify And Differentiate Combination Products

SPONSOR

2025 BioPlan's 22nd Annual Survey--Biopharmaceutical Manufacturing

For over 20 years, we continue to be the leader in providing the biopharma industry's most comprehensive benchmarking analysis. We invite you to participate in our 22nd Annual Survey in Biopharmaceutical Manufacturing! For all completed, qualified responses, we'll send an Amazon egift card, a copy of the summary results (mid-2025), and our 2025 Top Trends in Biomanufacturing White Paper.

FEATURED EDITORIAL

How To Identify And Differentiate Combination Products

Host Tom von Gunden dives into Chapter 2 of The Combination Products Handbook: A Practical Guide for Combination Products and Other Combined Use Systems (CRC Press) with the book’s editor and Chapter 2 author, Susan Neadle. Together, they explore key aspects of product development and the global regulatory landscape, addressing the central question posed by the chapter title: “What Is a Combination Product?”

A New Approach To ISO 14971 For Better Medical Device Risk Analysis

This article puts a new lens on the risk model in Annex C of ISO 14971 using relational risk analysis to describe a better approach for understanding and managing medical device risks.

INDUSTRY INSIGHTS

Designing Delivery Devices For Older Adults With Cognitive Impairment

Leverage our insights to improve your human factors studies and ensure the effective inclusion of older adults with mild cognitive impairment.

Taste Masking 101: Sensory And Performance Evaluation

Learn how techniques and innovations in taste masking sensory and performance evaluation can help accelerate your formulation development and confirm desired taste profile.

Leveraging Autoinjector Innovation To De-Risk Biosimilar Development

A fundamental area in which biopharmaceutical companies can de-risk the launch process is by choosing a suitable autoinjector technology and partner.

Solving Delivery Challenges For Tolerogenic Vaccines

Discover innovative solutions for allergy immunotherapies with advanced delivery formats that address challenges like large molecule storage, aggregation, and protease activity.

Financial Considerations For Phase 2 Clinical Injectable Drug Manufacturing

Consider the importance of scalability and flexibility in the choice of an early-stage manufacturing strategy and how that decision impacts financial outcomes for a drug development program.

Nasal Inhalation Delivery – An Introduction Guide

Unlock the potential of nasal inhalation for delivering active pharmaceutical ingredients by evaluating the advantages of both liquid and dry powder formulations as companies innovate to enhance therapies.

Unlocking The Potential Of Self-Administered Injectable Medicines

Get an inside look into how patients and healthcare providers choose self-administered injectables and on-body delivery systems for managing chronic conditions.

SOLUTIONS

Nasal Spray Development And Manufacturing Services

Medical Device Risk Management

Global Experts In Nanotechnology And Drug Particle Engineering